GSK’s Nucala bags another China approval, but biggest test yet to comenews2025-01-03T12:02:52+00:00January 3rd, 2025|Endpoints News|
Biopharma to raise more than 1,000 drug prices in 2025, advisory firm predictsnews2025-01-02T20:14:01+00:00January 2nd, 2025|Endpoints News|
Regeneron buys London-based ocular biotechnews2025-01-02T18:46:53+00:00January 2nd, 2025|Endpoints News|
FDA approves subcutaneous version of Bristol Myers’ Opdivonews2024-12-27T16:59:44+00:00December 27th, 2024|Endpoints News|
BioNTech settles with NIH, UPenn in Covid vaccine disputes and will pay royaltiesnews2024-12-27T15:23:42+00:00December 27th, 2024|Endpoints News|
Federal appeals court says Teva must delist Orange Book inhaler patentsnews2024-12-23T19:08:01+00:00December 23rd, 2024|Endpoints News|
CMS explains what went into its first round of drug price negotiationsnews2024-12-23T18:55:19+00:00December 23rd, 2024|Endpoints News|
Viatris’ India-based manufacturing site blocked from shipping 11 generic drugs to USnews2024-12-23T18:06:05+00:00December 23rd, 2024|Endpoints News|
Sumitomo’s overactive bladder drug adds another indicationnews2024-12-23T17:39:13+00:00December 23rd, 2024|Endpoints News|
FDA approves Lilly weight loss drug Zepbound for sleep apneanews2024-12-23T14:27:20+00:00December 23rd, 2024|Endpoints News|
